Results 251 to 260 of about 989,911 (307)

Noninferiority Randomized Controlled Trials

Journal of Investigative Dermatology, 2022
From 2005 to 2015, the publication of noninferiority trials increased by six-fold. Noninferiority trials assess whether a new treatment's efficacy is comparable with that of the standard of care and have several appeals. Noninferiority trials can evaluate for both noninferiority and superiority of a new treatment.
Kevin S. Kim, An-Wen Chan, Emilie P. Belley-Côté, Aaron M. Drucker   +3 more
openaire   +2 more sources